p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

Daniele Bergamaschi(Ludwig Cancer Research), Milena Gasco(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Louise Hiller(Cancer Research UK Clinical Trials Unit), Alexandra Sullivan(Ludwig Cancer Research), Nelofer Syed(Ludwig Cancer Research), Giuseppe Trigiante(Ludwig Cancer Research), Işık G. Yuluğ(Bilkent University), Marco Merlano(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Gianmauro Numico(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Alberto Comino(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Marlene Attard(Ludwig Cancer Research), Olivier Reelfs(Ludwig Cancer Research), Barry A. Gusterson(Western Infirmary), Alexandra Bell(Western Infirmary), Victoria J. Heath(Western Infirmary), Mahvash Tavassoli(King's College School), Paul J. Farrell(Ludwig Cancer Research), Paul Smith(Brunel University of London), Xin Lü(Ludwig Cancer Research), Tim Crook(Ludwig Cancer Research)
Cancer Cell
April 1, 2003
10.1016/s1535-6108(03)00079-5
Cited by 458Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis